| Sep 19 |
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
|
| Sep 18 |
Organon to acquire Roivant company Dermavant for $1.2B
|
| Sep 18 |
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
|
| Sep 6 |
Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma
|
| Aug 22 |
Organon & Co.: Cheap With Caveats
|
| Aug 21 |
Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
|
| Aug 20 |
Eli Lilly, Organon expand distribution deal for migraine drug
|
| Aug 20 |
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
|
| Aug 15 |
Investors Shouldn't Be Too Comfortable With Organon's (NYSE:OGN) Earnings
|
| Aug 12 |
Roth MKM says Small-Cap Value reaches key technical support, lists 14 "bullish" stocks
|
